arrow
G

Genichiro Ishii

Juntendo University Graduate School of Medicine
H指数:67
被引数:1.4万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Thoracic recurrence after complete gross resection in advanced ovarian cancer: The clinical impact of occult subdiaphragmatic lymphatic invasion

晚期卵巢癌完全大块切除术后胸部的复发:隐匿膈下淋巴侵犯的临床影响

2026-10-310
PRE
Histologic patterns of metastatic lymph nodes and recurrence patterns in resected pN1–2 lung adenocarcinoma

切除的pN1–2肺腺癌中转移淋巴结的病理模式和复发模式

2026-08-180
PRE
Transgelin Expression in Activated Cancer-Associated Fibroblasts Regulates Stromal Contractility and Promotes Colon Cancer Progression

激活的癌症相关成纤维细胞中Transgelin的表达调控基质收缩性并促进结肠癌进展

2026-04-080
OAAI
Extranodal extension in lung adenocarcinoma: pathological insights and its implication as a histological marker of clinical aggressiveness

肺腺癌中的结外侵犯:病理学见解及其作为临床侵袭性组织学标志物的意义

2025-12-160
PRE
Characterization of early-onset gastritis during zolbetuximab-containing chemotherapy in CLDN18.2-positive gastric cancer

CLDN18.2阳性胃癌患者接受含zolbetuximab化疗期间早期胃炎的特征分析

2025-09-300
OAAI
Single-cell spatial analysis with Xenium reveals anti-tumour responses of CXCL13 + T and CXCL9+ cells after radiotherapy combined with anti-PD-L1 therapy

Xenium的单细胞空间分析揭示了放疗联合anti-PD-L1治疗后CXCL13 T和CXCL9细胞的抗肿瘤反应

2025-07-160
OA
Solid Predominant Histology and High Podoplanin Expression in Cancer-Associated Fibroblast Predict Primary Resistance to Osimertinib in EGFR-Mutated Lung Adenocarcinoma

肿瘤相关成纤维细胞中实性占优势的组织学和podotlanin的高表达可预测EGFR突变的肺腺癌对奥希替尼的原发性耐药

2025-03-011
OA
Spatially resolved gene expression profiling of tumor microenvironment reveals key steps of lung adenocarcinoma development
2024-12-060
OAAI
Efficacy of antibody drug conjugate (ADC) by mRNA expression of targeted genes in advanced solid tumors: SCRUM-Japan MONSTAR-SCREEN-2

抗体药物偶联物(ADC)在晚期实体瘤中的疗效:基于靶向基因的mRNA表达,SCRUM-Japan MONSTAR-SCREEN-2

2024-09-010
PRE
The SCRUM-MONSTAR Cancer-Omics Ecosystem: Striving for a Quantum Leap in Precision Medicine

Scrum-monstar癌症组学生态系统: 努力实现精准医学的飞跃

2024-07-161
OAAI